Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Leukemia 15Lymphoma 7Leukemia, Myeloid, Acute 6Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell, Marginal Zone 2Leukemia, T-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Burkitt Lymphoma 2Philadelphia Chromosome 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Chronic-Phase 1Congenital Abnormalities 1Blast Crisis 1

Interventions

Imatinib Mesylate 5Cyclophosphamide 4fludarabine 3Vincristine 3Methotrexate 3Dexamethasone 3Dasatinib 3Cytarabine 3fludarabine phosphate 2Prednisone 2Daunorubicin 2venetoclax 1thymoglobulin 1ponatinib 1peginterferon alfa-2a 1olverembatinib 1flumatinib 1blinatumomab 1Whole-Body Irradiation 1Tacrolimus 1Rituximab 1Prednisolone 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Mycophenolic Acid 1Mitoxantrone 1Mercaptopurine 1Melphalan 1Magnetic Resonance Imaging 1Interferons 1Inotuzumab Ozogamicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Philadelphia Chromosome × Idarubicin × Lymphoid × Clear all
NCT01990807 2013-11-21

Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia

ChineseAMS

Phase 4 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Philadelphia Chromosome, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡